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Sumnlary 
Staphylococcal enterotoxin A  (SEA)  has two distinct binding sites for major histocompatibility 
complex (MHC)  class II molecules.  The  aspartic acid located at position 227  (D227)  in  the 
COOH terminus of SEA is one of the three residues involved in its interaction with the DR[3 
chain, whereas the phenylalanine 47 (F47)  of the NH  2 terminus is critical for its binding to the 
DRot  chain.  Upon  interaction  with  MHC  class  II molecules,  SEA  triggers  several  cellular 
events leading to cytokine gene expression.  In the present study, we have demonstrated that, 
contrary to wild-type SEA, stimulation of the THP1 monocytic cell line with SEA mutated at 
position 47 (SEAF4v~ or at position 227  (SEAD227t0 failed to induce interleukin 113 and tumor 
necrosis factor-o~ messenger RNA expression. Pretreatment of the cells with a 10-fold excess of 
either SEAFa7A or SEAD227  A prevented the  increase in  cytokine messenger RNA induced  by 
wild-type SEA. However, cross-linking of SEAF47A or SEAD227  A bound to MHC class II molecules 
with F(ab')2 anti-SEA mAb leads to cytokine gene expression, whereas cross-linking with F(ab) 
fragments had no effect. Taken together, these results indicate that cross-linking of two MHC 
class II molecules by one single SEA molecule is a requirement for cytokine gene expression. 
B 
acterial superantigens  (SAGs),  including  the  Staphylo- 
coccus  aureus  products  staphylococcal  enterotoxin  A 
(SEA),  staphylococcal  enterotoxin  B  (SEB),  and  toxic 
shock syndrome toxin  1  (TSST1),  have potent  effects on 
the immune system and a pathophysiological role in toxic 
shock  (1).  Upon  interaction  with  their  natural  receptors, 
the  MHC  class II molecules  (2-4),  SAGs  activate a large 
fraction of T  cells (5) and induce a variety of cellular events 
in MHC class II-expressing cells, such as cell-cell adhesion 
(6), inflammatory cytokine gene expression (7), and T  cell- 
dependent B  cell proliferation and differentiation  (8).  The 
crystal  structure  of the  TSST1-DR1  and  the  SEB-DR1 
complexes has been solved, and the residues involved in the 
interaction with MHC  class II molecules are well defined 
(9,  10).  The  crystal structure  of the  SEA-DR  complex is 
not yet available. However, it was shown that SEA has two 
distinct  binding  sites  for  HLA-DR  molecules  (11).  The 
first  site  is  located  in  the  COOH  terminus,  whereas  the 
second  is  located  in  the  NH2-terminal  domain  of SEA. 
Binding of SEA through its COOH  terminus to HLA-DR 
is Zn  2+ dependent, and this ion coordinates the interaction 
between histidine (H) at position 187 and 225, aspartic acid 
(D)  at position  227  of the  SEA,  and  the  histidine  81  of 
HLA-DR molecules' [3 chain  (12-15).  The phenylalanine 
at position 47  (F47),  located in the NH2-terminal domain 
of SEA, is critical for the second SEA-binding site (11). Ac- 
cordingly,  our  recent  data  indicate  that  SEA  interacts 
through its NH  2 terminus with the DRci chain in a manner 
similar to  SEB  (Thibodeau, J.,  M.  Dohlsten,  I.  Cloutier, 
C. L6veill~,  P. Bjork,  T. Kalland, W.  Mourad,  and R.  P. 
Sekaly, manuscript in preparation).  This finding led us to 
propose that the two binding sites  on SEA may allow the 
cross-linking of two MHC class II molecules. 
In  the  present  study,  we  have  used  SEA  mutants  that 
bind either to the MHC class I! cl or [3 chain,  to demon- 
strate that cross-linking two MHC class II molecules on the 
cell surface by a single SEA molecule is a requirement for 
inflammatory cytokine gene expression.  This finding may 
be fundamental to the understanding of the mechanisms of 
action of bacterial SAGs. 
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Generation of Recombinant  SEA  Mutants.  Four different SEA 
mutants were generated as we have previously described:  (a)  The 
aspartic  acid at position 227 was substituted by alanine  (SEAD227A) ; 
(b)  the  phenylalanine  at  position  47  was  substituted  by  alanine 
(SEAF47a); (c) double mutants  in which F47 and D227  were sub- 
stituted by alanines were generated (SEAF47A/D227A);  and (d) a con- 
trol mutant  in which  the  asparagine  at position  128  was  substi- 
tuted by alanine was generated (SEAN128A). Briefly, the SEA gene 
was cloned from S.  aureus (16),  and its sequence was found to be 
identical to a published one (17).  The SEA gene was expressed in 
Escherichia coli,  using  the  regulatory  elements  of staphylococcal 
protein A for transcription and translation and as a synthetic signal 
sequence for secretion (18).  The SEA mutants F47A, D227A, and 
N128A and the double mutant  F47A/D227A were  obtained by 
alanine  substitutions  using oligonucleotide primers  and  PCP,.  A 
unique restriction enzyme site was  introduced  into  each mutant 
to enable its identification. Each mutation was  confirmed by se- 
quencing the relevant portion of the gene. The SEA was then ex- 
pressed  in E.  coli K12 strain  UL635  and purified from the peri- 
plasmatic  extract by  affinity chromatography  using immobilized 
anti-SEA antibodies.  The purity of these mutants  was confirmed 
by SDS-PAGE followed by Coomassie blue staining or immuno- 
blot analysis  with SEA-specific mAbs. 
Cells.  The  THP1  monocytic  human  cell line was  obtained 
from  American  Type  Culture  Collection  (P,  ockville, MD)  and 
maintained in P,  PMI 1640 medium containing 10% FCS and anti- 
biotics. This cell line expresses very low levels of HLA-DP, mol- 
ecules,  whereas  it is  completely negative for HLA-DQ and  -DP 
(19).  To induce high levels of MHC class II molecules, cells were 
stimulated with IFN-~/(50 U/ml) for 48 h. Before use, cells were 
washed twice with HBSS. 
Flow Cytometric Analysis.  Binding of SEA wild type  (SEAwt) 
and  mutants  to  IFN-',/-treated  THP1  cells  was  determined  by 
flow cytometric analysis.  Cells were first  incubated with  1 b~g of 
SEAwt or SEA mutants  (2  ￿  105 cells per sample). After 3 h of in- 
cubation,  the  cells were  washed  and  resuspended  in  100  btl  of 
staining buffer containing  1  I.tg of anti-SEA mAb.  30  rain later, 
the  cells were washed,  and rabbit  anti-mouse  IgG-FITC conju- 
gate was added and incubated for 30 min. Washed cells were then 
analyzed by FACScan  |  (Becton Dickinson &  Co.,  Cockeysville, 
MD). A  total of 104 cells gated by light scatter on live cells were 
analyzed. 
Binding  Inhibition Assay.  The capacity of the SEA mutants  to 
inhibit binding of the 125I-radiolabeled SEAwt to  IFN-~/-treated 
THP1  cells was determined as we have previously described (20). 
Cells (5  ￿  105) were incubated for 3  h  at 37~  with 12SI-labeled 
SEA (20 ng) in 200  t*1 of binding buffer (RPMI  1640 plus 2.5% 
FCS  and  0.02%  sodium  azide).  The  cells  were  then  pelleted 
through an oil cushion (84% silicon oil and 16% mineral oil), and 
their activity (cpm)  was  determined  using a  gamma  counter.  In 
the competitive tests,  the cells were first incubated for 30 rain at 
37~  with cold SEAwt or SEA mutants.  All tests were performed 
in triplicate, and SEM was < 10% in all assays. 
Northern Blot Analysis.  Stimulation conditions for each exper- 
iment  are  detailed  in  the  appropriate  figure  legends.  IkNA  was 
purified  according  to  the  classical  method  (21),  and  10  txg  of 
P,  NA  was  loaded  onto  1%  agarose  gels.  The  RNA  was  then 
transferred onto Hybond-N filter paper and was hybridized with 
random  primer-labeled  cDNA  probes  for  IL-113 and  TNF-oL 
(22).  Equal  loadings  of lkNA  were  confirmed  by  hybridization 
with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA 
probe. The messenger RNA (mP,  NA) hybridizing with the cDNA 
probes was visualized by autoradiography. 
Results  and Discussion 
Dimerization  or  even  multimerization  of  receptors  is 
commonly  required  for signal  transduction  (23).  To  assess 
the  biological  function  of the  two  SEA-binding  sites,  we 
examined the capacity of SEA mutants  to trigger inflamma- 
tory cytokine gene expression in THP1  cells. As previously 
demonstrated  (24),  stimulation  of  IFN-~/-treated  THP1 
Figure  1.  SEAF47A  and SEAn227  A failed to induce  IL-113 and  TNF-0~ 
mRNA expression in the THP1 monocytic cell line.  (A) Dose response 
and (B) time-course  of IL-113 and TNF-cx mRNA expression in IFN-y- 
treated THP1 monocytic cell line. Cells were treated with different con- 
centrations  (0.2-5  I.tg/ml) of SEAwt or SEA mutants for 1 h at 37~  or 
with 5 I~g/ml of SEAwt or SEA mutants  for increasing periods of time. 
Cells were then harvested, P,  NA was extracted, and 10 I~g of total RNA 
was loaded  in each lane, subjected  to  electrophoresis,  transferred  to ni- 
trocellulose  filters, and  hybridized  with a probe for IL-113 followed  by 
TNF-~x and the housekeeping  gene GAPDH as control for equal R.NA 
loading. 
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Figure  2.  Binding  of wild-type and  mutated  SEA to  IFN-"/-treated 
THP1 as detected by flow cytometry  (A), and the ability of SEA mutants 
to  inhibit  125I-labeled wild-type SEA binding  to  IFN-3,-treated  THP1 
(B). For flow cytometric analysis, cells were first incubated with SEAwt or 
SEA mutants, followed by anti-SEA mAb. Cells were then washed, rabbit 
anti-mouse IgG-FITC conjugate was added, and cells were incubated  for 
30 rain. Washed  cells were then analyzed by FACScan  |  For binding in- 
hibition  assay, cells were incubated  with 12SI-labeled SEA in the absence 
or the presence of cold SEAwt or SEA mutants.  Cells were then pelleted 
through an oil cushion (84% sihcon oil and 16% mineral oil), and their ac- 
tivity  (cpm) was determined  using a gamma counter.  All tests were per- 
formed in triplicate, and SEM was <10% in all assays. 
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MHC  class  II  molecules,  resulting in  IL-113  and  TNF-cx 
gene expression. Fig.  1 A  shows that stimulation of THP1 
cells with  SEAwt  for  1  h  induced  a  dose-dependent  in- 
crease in the levels of IL-113 and TNF-oL mRNA.  Signifi- 
cant levels of both  cytokines were  observed at concentra- 
tions as low as 0.2  ~g/ml. In contrast, mutants SEAra7A and 
SEAD227  A failed to induce any detectable inflammatory cy- 
tokine gene  expression at  even  the  highest toxin concen- 
trations used (5 ~g/ml). SEAN128  ^  still has the same activity 
as the SEAwt (Fig. 1 A). Detailed time-course experiments 
revealed that  SEAwt induces  an  early peak  of both  cyto- 
kines at 1 h, followed by a significant decrease after 2 and 3 h 
(Fig.  1  B). The  failure of SEAF47A and SEAD227  A to  trigger 
cytokine gene expression can be explained by the inability 
of these mutants  to  interact with MHC  class II molecules 
or by  the  absolute  requirement  for  SEA  interaction  with 
the two sites on MHC  class II molecules. To veil@ the first 
possibility, flow cytometric analysis and binding inhibition 
experiments were performed. Fig. 2 A  indicates that SEAwt 
and  SEAN128  A bound  equally well to  IFN-',/-treated THP1 
cells. In contrast, binding of SEA~47^ was less efficient (at least 
twofold less), whereas binding of SEAD227  A or SEAF47A/D227A 
was almost undetectable. The specificity and characteristics 
of the  binding were further addressed by determining the 
capacity of SEA mutants  to  inhibit the  binding of 125I-la- 
beled  SEAwt.  Binding  of 125I-1abeled  SEAwt  was  com- 
pletely inhibited by SEAwt and SEAN128  A. SEAFaTA  also sig- 
nificantly  inhibited  the  binding  of  ~2SI-labeled  SEAwt; 
however, a twofold excess of SEAF47A  was required to achieve 
Figure 3.  SEAF47A  and SEAD227  ^ inhibited SEAwt- (A) but not LPS-in- 
duced (B) IL-113 and TNF-~x mlLNA expression. (Q The inhibitory ef- 
fect of SEAD227A was completely abolished when  ceils pretreated with 
SEAD227A were washed before their stimulation with SEAwt. Cells  were 
first incubated with SEAF47A,  SEAD227A,  or SEAF47A/D227A  (5 g-g/ml) for 
2 h at 37~  Cells were then  either stimulated directly (A and B) with 
SEAwt (0.5 g-g/ml) or with LPS (1 g-g/ml), or washed twice with HBSS 
(C), and then stimulated with SEAwt (0.5 g.g/m]) for an additional 1 h. 
The reaction was stopped, total RNA was purified, and the levels oflL-1 [3 
and TNF-e~ mRNA were determined as described in the legend of Fig. 2. 
Figure 4.  (A) Cross-linking of SEAF47A or SEAD227  A bound to MHC 
class II molecules by F(ab')2 anti-SEA-specific  mAb is required for the in- 
duction  of IL-l[3  and TNF-ct mRNA expression. (B)  The  ability of 
F(ab')2 anti-SEA mAb to cross-hnk SEAD227 and induce cytokine gene 
expression  was completely abohshed when SEAD227^-pretreated  cells  were 
washed before the addition of F(ab')2 anti-SEA mAb. Cells were first in- 
cubated with SEAFqT^/D227A,  SEAt:47  A, SEAD227A,  or both (5 g-g/ml each) 
for 2 h at 37~  F(ab')2 anti-SEA mAb, F(ab) fragments of  anti-SEA mAb, 
or an isotype control (anti-SEB) (10 g-g/ml) were added directly to un- 
washed ceils (A) or to twice HBSS-washed ceils (B). 1 h later, the reaction 
was stopped, and IL-l[3 and TNF-ot mRNA expression was determined 
by Northern blot analysis  as described in the legend of Fig. 2. 
the  same  magnitude  of inhibition  seen  with  SEAwt  or 
SEAN12S^. In contrast, SEAD227A and SEAr47A/D227^ failed to 
affect  SEAwt  binding  (Fig.  2  B).  These  results  confirm 
those  observed  using  Raji  cells  or  DFLl-transfected  cells 
(1 1), and indicate that the failure of SEAF47A to induce gene 
expression is not due to its inability to bind MHC  class II 
molecules. 
To verify the second possibility, we examined the effect 
of blocking  one  of those  sites  on  the  signal  induced  by 
SEAwt.  Pretreatment of THP1  cells with a  10-fold excess 
of SEAF47A or SEAD227  A but not  SEAF47A/D227A completely 
inhibited  the  SEAwt-induced  responses  (Fig.  3  A).  The 
same treatment failed to affect LPS-induced cytokine gene 
expression (Fig. 3  B),  demonstrating the  specificity of this 
effect. This inhibition is not the result of a negative signal, 
since it requires the continuous presence of SEAD227A dur- 
ing SEAwt stimulation. Removal of the SEAD227^ excess by 
washing  abolished  its  capacity to  inhibit  SEAwt-induced 
responses  (Fig.  3  C).  These  results  confirm  our  previous 
data (11,  and Thibodeau, J.,  M.  Dohlsten,  I.  Cloutier,  C. 
Ltveill~,  P.  Bjork,  T.  Kalland,  W.  Mourad,  and  R.  P. 
Sekaly, manuscript in preparation), showing that SEAD227^ 
binds to DRc~ with low affinity (10 -5 M,  undetectable by 
cytometric analysis or binding inhibition assay), but it is still 
capable of preventing SEAwt from occupying the oL chain 
binding site (Fig. 3  C).  These results led to the hypothesis 
that SEA must cross-link two  MHC  class II molecules by 
occupying both  MHC  class  II  binding  sites  to  efficiently 
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sence  of gene  expression  observed  when  both  mutants 
were added simultaneously (Fig. 4 A). 
Two possible models emerge to explain the results: First, 
multimerization of MHC class II molecules must occur in a 
specific topology involving a simultaneous interaction with 
both DRcr and -[3 chains; second, multimerization of MHC 
class  II molecules  through  either  the  o~  or 13  chain  could 
lead to signal transduction.  To differentiate between  these 
two models, SEA mutants were added independently or in 
combination,  and  then  cross-linked  with  F(ab')2  or F(ab) 
forms of an SEA-specific mAb. Cross-linking of SEAF47A or 
SEAD227  A with  F(ab')2  anti-SEA  mAb  leads  to  cytokine 
gene  expression,  whereas  F(ab)  fragments  or  the  isotype 
control had no effect (Fig. 4 A). A similar response was ob- 
tained  with  cells  stimulated  with  either  mutant  alone  or 
with  a  combination  of both.  Cross-linking  SEAF47A/D227A 
with  F(ab')2  anti-SEA  mAb  did  not  induce  IL-113  and 
TNF-er gene expression. Accordingly, cross-linking of class 
II molecules,  whether  through  the  a  or  13 chain,  is suffi- 
cient for SEA-induced cytokine gene expression.  The fail- 
ure  of F(ab)  anti-SEA mAb to induce any response  is not 
due to the inability of these fragments to bind to SEA, since 
Western  blot analysis  clearly demonstrates  that  F(ab)  frag- 
ment recognized the  SEA mutants  in  the  same  fashion  as 
F(ab')2  (data  not shown).  Once  again,  washing SEAD227  A- 
pretreated  cells  before  their  stimulation  with  F(ab')2 anti- 
SEA abolished  this  response  (Fig.  4  B).  Altogether,  these 
results indicate that the mere aggregation of MHC  class  II 
molecules  by SEA is  sufficient  to  induce  signal  transduc- 
tion,  a finding compatible  with  the  fact that antibodies  to 
several  DR  epitopes  are  also  capable  of eliciting  similar 
events (22). 
These results support the recent hypothesis that a single 
SEA molecule can cross-link two MHC  class II molecules 
on the cell surface (11). Here we show that SEA cross-link- 
ing  of MHC  class  II  molecules  leads  to  major  effects  on 
APCs,  which  in  turn  could  enhance  T  cell  activation. 
Cross-linking of class II molecules in a nominal antigen re- 
sponse  leads  to  the  up-regulation  of costimulatory  mole- 
cules  in APCs  (25).  Similarly,  the  cross-linking  suggested 
by the current studies  also induces the expression  of cyto- 
kines,  which can modulate  cellular immune  responses  (8). 
Considering the  crystal structure  of SEB  (9),  TSST1  (10), 
and  SEA  (26),  it  seems  these  three  toxins  bear  a  similar 
configuration,  and in all cases their interaction with MHC 
class  II molecules implicates  dimerization  of class II mole- 
cules or of the  toxins.  Indeed,  in the  SEB:DR1  cocrystal, 
the superdimer of class II dimers was present, and the pres- 
ence of a TSST1  dimer was  also observed in the  TSSTI: 
DR1  cocrystal.  We  hereby  show  that  SEA  can  dimerize 
class  II  molecules  by  interacting  with  two  different  sites, 
which appears to be a prerequisite for their exquisite effects 
on T  cells and on APCs. 
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